Brooklyn ImmunoTherapeutics
BTX
$0.58
Share price
-4.07%
Change (1 day)
N/A
Change (1 year)
Categories
Earnings for Brooklyn ImmunoTherapeutics (BTX)
Earnings in 2021 (TTM): -$0.11 B
According to Brooklyn ImmunoTherapeutics's latest financial reports the company's current earnings (TTM) are -$0.11 B. In 2020 the company made an earning of -$0.03 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Brooklyn ImmunoTherapeutics from 2020 to 2021
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2021 (TTM) | -$0.11 B | 306.39% |
| 2020 | -$0.03 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $9.82 B | -9,230.70% | 🇫🇷 France |
 Baxter BAX | $1.47 B | -1,472.12% | 🇺🇸 USA |
 Geron GERN | -$0.12 B | 5.82% | 🇺🇸 USA |
 Genetic Technologies GENE | -$3.94 M | -96.34% | 🇦🇺 Australia |
 Teva Pharmaceutical Industries TEVA | $0.36 B | -442.80% | 🇮🇱 Israel |
 Bio-Techne TECH | $0.24 B | -324.39% | 🇺🇸 USA |